PharmaCyte Biotech, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold PMCB, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
5
Funds holding
$28460
Total value held
Buying
3 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Northern Trust Corp | $25120 | 32624 | -2977 | -8.36% |
| 2 | Ubs Group Ag | $3189 | 4142 | +4142 | NEW BUY |
| 3 | Barclays Plc | $148 | 192 | +192 | NEW BUY |
| 4 | Morgan Stanley | $2 | 2 | +1 | +100.00% |
| 5 | Blackrock, Inc. | $1 | 1 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.